Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*

Business Wire March 12, 2014

Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer's Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone's Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence of Tikosyn® Capsules

Business Wire March 6, 2014

IPO Report: Aquinox Pharmaceuticals (AQXP)

Equities.com March 6, 2014

Wall Street Celebrates Bull Market's 5th Birthday Modestly

Equities.com March 6, 2014

Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array

PR Newswire March 5, 2014

Japan's Bold Initiative in Regenerative Medicine and Who the Big Winners Might Be

Accesswire March 3, 2014

Nodality, Inc. Appoints Ralph Snyderman, M.D., to Board of Directors

Business Wire February 26, 2014

Pfizer Announces FDA Approval to Include Radiographic Data on Reduction of Progression of Structural Joint Damage for Adults with Moderately to Severely Active Rheumatoid Arthritis in Labeling for XELJANZ® (tofacitinib citrate)

Business Wire February 24, 2014

Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*

Business Wire February 24, 2014

In a Subanalysis, Eliquis® (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation

Business Wire February 21, 2014

Housing Data and Fed Minutes Send Wall Street Lower

Equities.com February 19, 2014

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

Business Wire February 18, 2014

Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership

Accesswire February 13, 2014

Northeast Shows Nearly $7 Billion in Reasons to Love the Life Science Industry's Capital Investments, an Industrial Info News Alert

Marketwired February 13, 2014

IPO Report: Flexion Therapeutics (FLXN)

Equities.com February 11, 2014

Pfizer Statement on Today's Joint Meeting of FDA Advisory Committees

Business Wire February 11, 2014

RDInvesting Provides Investors with Free In-Depth Equity Reports on AGN, FRX, GILD and PFE

Accesswire February 5, 2014

Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies

Business Wire February 5, 2014

Pain Therapeutics Reports 2013 Financial Results and Provides Guidance for 2014

Globe Newswire February 4, 2014

TrendingWallStreet.com Initiates Trend Analysis on GFOX, CMCSA, SKTO, and PFE

Accesswire February 4, 2014